Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles

The goal of this study is to compare the cumulative pregnancy rates after 4 artificial inseminations with donor (IAD) in non-sterile women with plasma AMH levels > and < 1.1 ng/mL.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility, Female Anti-Mullerian Hormone Deficiency Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Infertility Urogenital Diseases

Age range

25 year–39 year

Sex eligibility

Female

Study type

Observational

Primary location

Fertty International

Barcelona, 08010, Spain

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

IUI cycles with sperm donors either due to severe oligoasthenoteratozoospermia in the partner (defined as a motile sperm count (MSC) < 5 million in the ejaculate) or for social reasons, with up to 4 attempts accounted for.

Exclusion criteria

BMI >30
Infertility due to bilateral tubal factor
Endometriosis grade II-IV.

Treatment and study plan

Intrauterine Insemination

Procedure

Intrauterine insemination with sperm donors

Primary outcomes

Cummulative pregnancy rate

Time frame: 36 months

Pregnancy rate after 4 cycles of IUI

Sponsors and collaborators

Lead sponsor

Jose Antonio Moreno

Other

Collaborators

Universitat Autonoma de Barcelona

Registry information

Official study title

Pregnancy Prediction in Non-sterile Patients After 4 Intrauterine Inseminations With Donor Using Anti-Müllerian Hormone

Important dates

Study start: 2020
Primary completion: 2022
Study completion: 2023
First posted: Feb 16, 2024
Registry last updated: Feb 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed